Mefloquine hydrochloride
Mefloquine hydrochloride: 2 brands, 4 generics; first approved May 02, 1989; generic available.
Generic available: 4 ANDA applications approved.
Brand (NDA) products
- LARIAMRLDROCHENDA 0195911989
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued - - MEFLOQUINE HYDROCHLORIDEUS ARMY WALTER REEDNDA 0195781989
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued -
Generic (ANDA) products (4)
- MEFLOQUINE HYDROCHLORIDEHIKMA INTL PHARMSANDA 0776992010
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued - - MEFLOQUINE HYDROCHLORIDEHIKMAANDA 0765232004
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued - - MEFLOQUINE HYDROCHLORIDERSBARRANDA 0763922003
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Rx AB - MEFLOQUINE HYDROCHLORIDECHARTWELL RXANDA 0761752002
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Rx AB
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Approval history
Approvals span 1989–2010 across 6 FDA applications.
Mefloquine hydrochloride: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
Assyro Intelligence
Ask anything about Mefloquine hydrochloride
Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.
Evaluating for a team? Book a demo